Prostate cancer. Part 1: Review of cell kinetics over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)

Der Pathologe
B Helpap, L Bubendorf

Abstract

Using tritium-labeled thymidine histoautoradiography, the AgNOR staining technique and Ki67-MIB-1 immunohistochemistry to study cell kinetics, prostate cancer can be subdivided into slowly, moderately and rapidly proliferating tumors. These are important supplementary methods and prerequisites for a grading as low, intermediate and high-grade in addition to classical histology and cytology. Cytometry of DNA can confirm the cell kinetics of prostate cancer by detection of a predominance of diploid or aneuploid cell nuclei but should only be evaluated together with histological investigations. All histology-based analyses of cell kinetics encompass the classical highly and poorly differentiated glandular and cribriform patterns as well as solid undifferentiated structures and the various subcategories. The malignancy grading of prostate cancer can result from the summation of histological grading and cell kinetic analyses, as long as the named investigations are included. The future perspectives of individualized therapy options, including active surveillance in early low-grade and also for high-grade prostate cancer and new antihormonal treatment in advanced disease, may increasingly rely on tissue biomarkers and advanced techno...Continue Reading

References

Jan 1, 1981·Virchows Archiv. A, Pathological Anatomy and Histology·B Helpap
Jan 1, 1980·Virchows Archiv. A, Pathological Anatomy and Histology·B Helpap
Jan 1, 1995·World Journal of Urology·B Helpap, C Riede
Mar 17, 1999·The American Journal of Surgical Pathology·J S RossB V Kallakury
Dec 7, 2000·Journal of the National Cancer Institute·N R MucciK J Pienta
Jul 5, 2003·World Journal of Urology·C DeliveliotisV Protogerou
Nov 1, 2005·Scandinavian Journal of Urology and Nephrology·Lars HäggarthLars Egevad
Jan 4, 2012·Histopathology·Glen Kristiansen
Dec 12, 2012·Development·Donald T Fox, Robert J Duronio
Feb 2, 2013·Frontiers in Pharmacology·Michael T BarrettDaniel D Von Hoff
Oct 19, 2013·The Journal of Clinical Investigation·Michael C HaffnerSrinivasan Yegnasubramanian
Nov 12, 2013·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
Feb 4, 2014·Virchows Archiv : an International Journal of Pathology·Theodorus H Van der Kwast
Apr 2, 2015·Nature·Gunes GundemG Steven Bova
Sep 9, 2015·Urologia Internationalis·Burkhard HelpapHans-Helge Seifert
Sep 15, 2015·Analytical Cellular Pathology (Amsterdam)·Alex StepanClaudiu Margaritescu
Jan 27, 2016·Der Pathologe·G KristiansenUNKNOWN Graduierungskommittee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.